US FDA pathway opens to SCENESSE® following Fast Track designation for treatment of EPP
06 juil. 2016 08h00 HE
|
Clinuvel Pharmaceuticals Limited
FDA awards Fast Track Designation¹ to expedite review of SCENESSE® in EPPNDA filing allowed on a rolling basisFDA hosting a Scientific Workshop² on EPP to learn more about disease and drug treatment ...